Spire Healthcare confirms 2017 guidance
FTSE 250 hospital group Spire Healthcare confirmed its previous guidance for 2017 on Tuesday.
FTSE 250
20,508.75
15:45 15/11/24
n/a
n/a
FTSE 350
4,453.56
15:45 15/11/24
n/a
n/a
FTSE All-Share
4,411.85
15:45 15/11/24
n/a
n/a
Health Care Equipment & Services
10,430.75
15:44 15/11/24
0.23%
23.76
Spire Healthcare Group
220.00p
15:29 15/11/24
0.46%
1.00p
The group, which is the second largest provider of private healthcare in the UK, continues to expect revenues of between £929m and £932m and underlying earnings before interest, tax, depreciation and amortisation of £149m to £151m. In addition, net debt at the end of December is expected to be around £465m.
Spire is due to announce its preliminary results for the full year on 2 March, with guidance for the 2018 full financial year also due to be given.
At 0805 GMT, the shares were down 1.7% to 242.35p.